Scholars Central

PerspectivePublished 21 Dec 2022

HIV-1 Latent Reservoir and Its Treatment

Authors: Siddhartha Norgay

HIV: Current Research

Volume 7 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The initial identification of the human immunodeficiency virus 1 (HIV-1) , antiretroviral therapy (ART), a targeted treatment, has successfully kept the observed plasma viremia below a very low level, and the method has advanced quickly. However, a sudden discontinuation of the medication would unavoidably result in HIV viral rebound and HIV progression because of the presence of the latent reservoir of replication-competent HIV-1 in patients receiving ART. Therefore, prior to creating a treatment that completely wipes out the reservoir, it is imperative to gain a better knowledge of the HIV-1 latent reservoir (LR). HIV-1 can spread from cell to cell as well as through the release of cell-free particles. There is growing evidence that cell-to-cell transmission is more effective than cell-free transmission of particles and may have an impact on HIV-1 infection pathogenesis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in HIV: Current Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHIV: Current Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Siddhartha Norgay”